annual cash & cash equivalents:
$387.88M-$9.57M(-2.41%)Summary
- As of today (September 14, 2025), PCVX annual cash & cash equivalents is $387.88 million, with the most recent change of -$9.57 million (-2.41%) on December 31, 2024.
- During the last 3 years, PCVX annual cash & cash equivalents has risen by +$318.89 million (+462.26%).
- PCVX annual cash & cash equivalents is now -53.53% below its all-time high of $834.66 million, reached on December 31, 2022.
Performance
PCVX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$1.66B-$10.30M(-0.62%)Summary
- As of today (September 14, 2025), PCVX quarterly cash & cash equivalents is $1.66 billion, with the most recent change of -$10.30 million (-0.62%) on June 30, 2025.
- Over the past year, PCVX quarterly cash & cash equivalents has increased by +$208.73 million (+14.37%).
- PCVX quarterly cash & cash equivalents is now -23.80% below its all-time high of $2.18 billion, reached on September 30, 2024.
Performance
PCVX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
PCVX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.4% | +14.4% |
| 3 y3 years | +462.3% | +368.7% |
| 5 y5 years | +557.7% | +305.2% |
PCVX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -53.5% | +462.3% | -23.8% | +368.7% |
| 5 y | 5-year | -53.5% | +557.7% | -23.8% | +575.5% |
| alltime | all time | -53.5% | +557.7% | -23.8% | +2717.1% |
PCVX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $1.66B(-0.6%) |
| Mar 2025 | - | $1.67B(-4.3%) |
| Dec 2024 | $387.88M(-2.4%) | $1.75B(-19.9%) |
| Sep 2024 | - | $2.18B(+50.1%) |
| Jun 2024 | - | $1.45B(-2.3%) |
| Mar 2024 | - | $1.49B(+37.6%) |
| Dec 2023 | $397.45M(-52.4%) | $1.08B(-14.7%) |
| Sep 2023 | - | $1.27B(-1.7%) |
| Jun 2023 | - | $1.29B(+56.6%) |
| Mar 2023 | - | $822.04M(-11.7%) |
| Dec 2022 | $834.66M | $931.38M(+157.1%) |
| Sep 2022 | - | $362.23M(+2.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $354.50M(+5.9%) |
| Mar 2022 | - | $334.64M(+36.0%) |
| Dec 2021 | $68.98M(-82.1%) | $245.97M(-11.7%) |
| Sep 2021 | - | $278.58M(-4.6%) |
| Jun 2021 | - | $292.12M(-9.0%) |
| Mar 2021 | - | $321.12M(-16.9%) |
| Dec 2020 | $386.20M(+554.8%) | $386.20M(-2.7%) |
| Sep 2020 | - | $397.05M(-3.2%) |
| Jun 2020 | - | $410.05M(+164.9%) |
| Mar 2020 | - | $154.79M(+162.5%) |
| Dec 2019 | $58.98M(-10.8%) | $58.98M |
| Dec 2018 | $66.09M | - |
FAQ
- What is Vaxcyte, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Vaxcyte, Inc.?
- What is Vaxcyte, Inc. annual cash & cash equivalents year-on-year change?
- What is Vaxcyte, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Vaxcyte, Inc.?
- What is Vaxcyte, Inc. quarterly cash & cash equivalents year-on-year change?
What is Vaxcyte, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of PCVX is $387.88M
What is the all time high annual cash & cash equivalents for Vaxcyte, Inc.?
Vaxcyte, Inc. all-time high annual cash & cash equivalents is $834.66M
What is Vaxcyte, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, PCVX annual cash & cash equivalents has changed by -$9.57M (-2.41%)
What is Vaxcyte, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of PCVX is $1.66B
What is the all time high quarterly cash & cash equivalents for Vaxcyte, Inc.?
Vaxcyte, Inc. all-time high quarterly cash & cash equivalents is $2.18B
What is Vaxcyte, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, PCVX quarterly cash & cash equivalents has changed by +$208.73M (+14.37%)